These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 6168746)

  • 1. Degradation of basic protein and Wolfgram protein in central nervous system by soluble enzymes of human peripheral polymorphonuclear leucocytes.
    Rastogi SC; Clausen J
    J Neurol Sci; 1981 Aug; 51(2):161-9. PubMed ID: 6168746
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Susceptibility of the Wolfgram proteins and stability of 2',3'-cyclic nucleotide 3'-phosphodiesterase of rat brain myelin to limited proteolytic digestion.
    Maruthi Mohan P; Sastry PS
    J Neurochem; 1987 Apr; 48(4):1083-9. PubMed ID: 2434616
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitation of the myelin-associated glycoprotein in human nervous tissue from controls and multiple sclerosis patients.
    Johnson D; Sato S; Quarles RH; Inuzuka T; Brady RO; Tourtellotte WW
    J Neurochem; 1986 Apr; 46(4):1086-93. PubMed ID: 2419505
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteolytic activity in CSF.
    Richards PT; Cuzner ML
    Adv Exp Med Biol; 1978; 100():521-7. PubMed ID: 80950
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppressive effect of triethyllead on entry of proteins into the CNS myelin sheath in vitro.
    Konat G; Clausen J
    J Neurochem; 1980 Aug; 35(2):382-7. PubMed ID: 6161219
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Susceptibility of the myelin-associated glycoprotein and basic protein to a neutral protease in highly purified myelin from human and rat brain.
    Sato S; Quarles RH; Brady RO
    J Neurochem; 1982 Jul; 39(1):97-105. PubMed ID: 6177834
    [No Abstract]   [Full Text] [Related]  

  • 7. Elevated neutral protease activity in myelin from brains of patients with multiple sclerosis.
    Sato S; Quarles RH; Brady RO; Tourtellotte WW
    Ann Neurol; 1984 Mar; 15(3):264-7. PubMed ID: 6202231
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Introduction and comments: myelination and demyelination.
    Einstein ER
    Adv Exp Med Biol; 1978; 100():1-16. PubMed ID: 80934
    [No Abstract]   [Full Text] [Related]  

  • 9. Degradation of myelin proteins by cathepsin B and inhibition by E-64 analogue.
    Yanagisawa K; Sato S; Miyatake T; Kominami E; Katsunuma N
    Neurochem Res; 1984 May; 9(5):691-4. PubMed ID: 6472569
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The presence of aldehyde-reacted proteins in normal and multiple sclerosis white matter.
    Epand RM; Dell K; Tonogai WT; Moscarello MA
    J Neurochem; 1985 Oct; 45(4):1223-7. PubMed ID: 2411868
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Degradation of the P0, P1, and Pr proteins in peripheral nervous system myelin by plasmin: implications regarding the role of macrophages in demyelinating diseases.
    Cammer W; Brosnan CF; Bloom BR; Norton WT
    J Neurochem; 1981 Apr; 36(4):1506-14. PubMed ID: 6167674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple sclerosis brain immunoglobulins stimulate myelin basic protein degradation in human myelin: a new cause of demyelination.
    de Rosbo NK; Bernard CC
    J Neurochem; 1989 Aug; 53(2):513-8. PubMed ID: 2473168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathogenesis of multiple sclerosis. Neurochemical and morphological studies on MS biopsies and autopsies.
    Röyttä M; Frey H; Riekkinen P; Rinne UK
    Eur Neurol; 1976; 14(3):209-18. PubMed ID: 58785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of Wolfgram W1 protein, myelin basic proteins and proteolipids in cultured oligodendrocytes by the electro-immunoblotting method.
    Nussbaum JL; Nussbaum F; Gensburger C; Araceli Espinosa de los Monteros MT; Roussel G; Labourdette G
    Neurosci Lett; 1983 Sep; 40(2):111-7. PubMed ID: 6195564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential molecular mimicry between the human endogenous retrovirus W family envelope proteins and myelin proteins in multiple sclerosis.
    Ramasamy R; Joseph B; Whittall T
    Immunol Lett; 2017 Mar; 183():79-85. PubMed ID: 28189601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 2'-3'-cyclic nucleotide 3'-phosphohydrolase activity in the central nervous system of a myelin deficient mutant (Shiverer).
    Mikoshiba K; Aoki E; Tsukada Y
    Brain Res; 1980 Jun; 192(1):195-204. PubMed ID: 6155175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reactivity to myelin antigens in multiple sclerosis. Peripheral blood lymphocytes respond predominantly to myelin oligodendrocyte glycoprotein.
    Kerlero de Rosbo N; Milo R; Lees MB; Burger D; Bernard CC; Ben-Nun A
    J Clin Invest; 1993 Dec; 92(6):2602-8. PubMed ID: 7504688
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neutral proteinases secreted by macrophages degrade basic protein: a possible mechanism of inflammatory demyelination.
    Norton WT; Cammer W; Bloom BR; Gordon S
    Adv Exp Med Biol; 1978; 100():365-81. PubMed ID: 80946
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myelin basic protein is affected by reduced synthesis of myelin proteolipid protein in the jimpy mouse.
    Fannon AM; Moscarello MA
    Biochem J; 1990 May; 268(1):105-10. PubMed ID: 1693071
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Demyelinating antibodies to myelin oligodendrocyte glycoprotein and galactocerebroside induce degradation of myelin basic protein in isolated human myelin.
    Menon KK; Piddlesden SJ; Bernard CC
    J Neurochem; 1997 Jul; 69(1):214-22. PubMed ID: 9202313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.